NO902600L - Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid. - Google Patents

Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid.

Info

Publication number
NO902600L
NO902600L NO90902600A NO902600A NO902600L NO 902600 L NO902600 L NO 902600L NO 90902600 A NO90902600 A NO 90902600A NO 902600 A NO902600 A NO 902600A NO 902600 L NO902600 L NO 902600L
Authority
NO
Norway
Prior art keywords
cellobioside
preparation
tigogenin
beta
tigogenin beta
Prior art date
Application number
NO90902600A
Other languages
English (en)
Norwegian (no)
Other versions
NO902600D0 (no
Inventor
Frank John Urban
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO902600D0 publication Critical patent/NO902600D0/no
Publication of NO902600L publication Critical patent/NO902600L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catalysts (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO90902600A 1989-06-13 1990-06-12 Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid. NO902600L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/365,588 US5010185A (en) 1989-06-13 1989-06-13 Processes for tigogenin beta-cellobioside

Publications (2)

Publication Number Publication Date
NO902600D0 NO902600D0 (no) 1990-06-12
NO902600L true NO902600L (no) 1990-12-14

Family

ID=23439483

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902600A NO902600L (no) 1989-06-13 1990-06-12 Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid.

Country Status (23)

Country Link
US (1) US5010185A (cs)
EP (1) EP0403150B1 (cs)
JP (1) JPH0637514B2 (cs)
KR (1) KR920002146B1 (cs)
AT (1) ATE114155T1 (cs)
AU (1) AU619986B2 (cs)
CA (1) CA2018722A1 (cs)
CZ (1) CZ279909B6 (cs)
DD (1) DD295164A5 (cs)
DE (1) DE69014152T2 (cs)
DK (1) DK0403150T3 (cs)
ES (1) ES2063269T3 (cs)
FI (1) FI902937A7 (cs)
HU (1) HU210689B (cs)
IE (1) IE64057B1 (cs)
IL (1) IL94650A (cs)
NO (1) NO902600L (cs)
NZ (1) NZ234028A (cs)
PL (3) PL163259B1 (cs)
PT (1) PT94337A (cs)
RU (1) RU2042688C1 (cs)
YU (1) YU47515B (cs)
ZA (1) ZA904527B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294703A (en) * 1992-05-01 1994-03-15 Eastman Kodak Company Process for preparing α-D-cellobiose octaacetate
JP2578399B2 (ja) * 1992-06-26 1997-02-05 ファイザー インク． ステロイド−β−Ｏ−セロビオシドヘプタアルカノエートの製造方法
DE69314031T2 (de) * 1992-06-26 1998-01-22 Pfizer Verfahren zur herstellung von per-acylierten glykosiden
CA2139104A1 (en) * 1992-06-26 1994-01-06 Michael P. Deninno Steroidal glycosides for treating hypercholesterolemia
US5530107A (en) * 1992-10-15 1996-06-25 Pfizer Inc. Method for making steroidal peracyl glycosides
CZ280195A3 (en) * 1993-04-28 1996-02-14 Pfizer Crystalline spirostanyl glycoside, monohydrate thereof, pharmaceutical composition based thereon and process for preparing crystalline steroidal glycoside
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
ES2074006B1 (es) * 1993-07-05 1996-03-16 Pfizer Glicosidos esteroidales para tratar hipercolesterolemia.
GB9806513D0 (en) * 1998-03-26 1998-05-27 Phytopharm Ltd Membrane-bound receptors
JP4589869B2 (ja) * 2002-07-12 2010-12-01 塩野義製薬株式会社 酸触媒として機能するゼオライト類似体の簡易な製造法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis

Also Published As

Publication number Publication date
ZA904527B (en) 1992-01-29
EP0403150B1 (en) 1994-11-17
PL163259B1 (pl) 1994-02-28
FI902937A0 (fi) 1990-06-12
HU903816D0 (en) 1990-11-28
KR910000779A (ko) 1991-01-30
PL285593A1 (en) 1991-07-01
DE69014152T2 (de) 1995-03-23
RU2042688C1 (ru) 1995-08-27
EP0403150A3 (en) 1992-06-17
IE902101A1 (en) 1991-01-02
FI902937A7 (fi) 1990-12-14
IE902101L (en) 1990-12-13
KR920002146B1 (ko) 1992-03-12
PL289135A1 (en) 1992-02-24
ES2063269T3 (es) 1995-01-01
IE64057B1 (en) 1995-07-12
PT94337A (pt) 1991-02-08
DK0403150T3 (da) 1995-01-16
JPH0637514B2 (ja) 1994-05-18
EP0403150A2 (en) 1990-12-19
CZ279909B6 (cs) 1995-08-16
PL163258B1 (pl) 1994-02-28
AU619986B2 (en) 1992-02-06
NZ234028A (en) 1991-10-25
YU114590A (en) 1991-10-31
YU47515B (sh) 1995-10-03
AU5707990A (en) 1991-08-01
HU210689B (en) 1995-06-28
PL289136A1 (en) 1992-02-24
DD295164A5 (de) 1991-10-24
US5010185A (en) 1991-04-23
HUT54708A (en) 1991-03-28
PL163219B1 (pl) 1994-02-28
DE69014152D1 (de) 1994-12-22
ATE114155T1 (de) 1994-12-15
CA2018722A1 (en) 1990-12-13
NO902600D0 (no) 1990-06-12
IL94650A (en) 1994-11-11
IL94650A0 (en) 1991-04-15
CZ289090A3 (en) 1995-04-12
JPH0331297A (ja) 1991-02-12

Similar Documents

Publication Publication Date Title
DE122004000017I1 (de) Monoklonaler Antik¦rper gegen ein Cytotoxin, denselben erzeugendes Hybridoma und Verfahren f}r die Herstellung des gereinigten Cytotoxin.
EP1022283A4 (en) NOVEL LIGNIN DERIVATIVE, MOLDINGS PRODUCED USING THIS DERIVATIVE AND PREPARATION METHOD
DE59003581D1 (de) Hochtemperatur-Verbund-Werkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung.
NO902600L (no) Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid.
HUT50860A (en) Water-proof briquette, process for its production and mixture of material applied by the production
HU9303638D0 (en) Reagent mixtures composition for blood-test, process for production of the composition, and process for examination blood-samples of glucose-content
DE3061360D1 (en) Process for preparing urethanes and their use as starting material in the preparation of isocyanates
FR2700770B1 (fr) Procédé de fabrication du 1,1,1,2-tétrafluoro-2-chloroéthane et du pentafluoroéthane.
EG22746A (en) Process and intermediates for the manufacture of pyridine 2,3 dicarboxylate compounds
HUT57753A (en) Process for producing benzthiazoles usable as anthelminic and their intermediates
IT8049362A0 (it) Procedimento per la produzione di 7-alcossicarbonil-6,8-dimetil-4idrossimetil-1-ftalazone e relativi prodotti intermedi
HU893637D0 (en) Process for manufacturing especially thermoisolating foamy material by means of mixing head formed for processing at least two components and working at low pressure as well as for applying this material, the mixer for carrying out the process and the isolating material manufactured by this process
HUT46077A (en) Process for the microbiological production of 9alpha-hydroxy-4-androsten-3,17-dione
HUT40679A (en) Process for producing 17-alpha-ethinyl-17-beta-hydroxy-18-methyl-4,15-estradien-3-on and the utilized new starting materials
DE69013722D1 (de) Nichtrostende Stahlbleche für Gebäudeaussenteile und Verfahren zum Herstellen derselben.
DE3563436D1 (en) Methyl substituted bicyclo ad2.2.1 bdheptane nitriles, process for production of these nitriles and their use as scents
YU40849B (en) Process for obtaining 1,3-benzoxazine-2,4-dione derivatives
EP0266878A3 (en) Chemical compounds
ZA919050B (en) Process for the production of 4,5,6,7-tetrahydro-imidazo-(4,5,ljk)(1,4)-benzidiazepine-2-(1h)-thiones as well as intermediate products
DE3461790D1 (en) Process for the production of partially hydrogenated derivatives of 2-nitro-1,1,1-trifluoralkanes
DE3867861D1 (de) Mehlzusammensetzung und verfahren zu deren herstellung.
IL63482A0 (en) 4-lower alkyl-3-phenoxypyridine-1-oxide and a method for its production
ATA98987A (de) Verfahren zum herstellen von stuetzausbauten im grosstunnel- bzw. stollenbau und nach diesem verfahren hergestellte stuetzausbauten
DE69302950D1 (de) Verfahren zur Herstellung von Stahlblechen und Stahlbleche, nach diesem Verfahren hergestellt
DE69011653D1 (de) Optisch aktive Verbindung, Intermediate hierzu, Verfahren zur Herstellung der Intermediate, und flüssigkristalline Zusammensetzung.